Significant associations of PAI-1 genetic polymorphisms with osteonecrosis of the femoral head

BMC Musculoskeletal Disorders

Volumn 12, Issue , 2011, Pages

  Kim, Hye Ok ^a   Cho, Chang Hoon ^a   Cho, Yoon Je ^b   Cho, Seong Ho ^a,c   Yoon, Kyung Sik ^a   Kim, Kang Il ^b  

^a Kyung Hee University Hospital   (South Korea)

^b Kyung Hee University College of Medicine   (South Korea)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; PLASMINOGEN ACTIVATOR INHIBITOR 1; STEROID; SERPINE1 PROTEIN, HUMAN;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; FEMUR HEAD NECROSIS; GENE FREQUENCY; GENE SEQUENCE; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PROMOTER REGION; RISK FACTOR; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; BLOOD CLOTTING DISORDER; CASE CONTROL STUDY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; PATHOLOGY;

ADULT; BLOOD COAGULATION DISORDERS, INHERITED; CASE-CONTROL STUDIES; FEMALE; FEMUR HEAD NECROSIS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYMORPHISM, GENETIC;

EID: 79960211146     PISSN: None     EISSN: 14712474     Source Type: Journal    
DOI: 10.1186/1471-2474-12-160     Document Type: Article

References (32)

1. Potential aetiological factors concerning the development of osteonecrosis of the femoral head. Zalavras C Dailiana Z Elisaf M Bairaktari E, Vlachogiannopoulos P Katsaraki A, Malizos KN,, Eur J Clin Invest 2000 30 215 221 10.1046/j.1365-2362.2000.00621.x 10691998 (Pubitemid 30153662)
2. Procoagulants and osteonecrosis. Jones LC Mont MA Le TB Petri M, Hungerford DS Wang P, Glueck CJ,, J Rheumatol 2003 30 783 791 12672200 (Pubitemid 36402774)
3. Thrombophilia and hypofibrinolysis: pathophysiologies of osteonecrosis. Glueck CJ Freiberg R Tracy T Stroop D, Wang P,, Clin Orthop Relat Res 1997 334 43 56 9005895 (Pubitemid 27034874)
4. Factor V leiden and prothrombin gene mutation: risk factors for osteonecrosis of the femoral head in adults. Bjorkman A Svensson PJ, Hillarp A Burtscher IM, Runow A Benoni G, Clin Orthop Relat Res 2004 425 168 172 15292803
5. Hypofibrinolysis, thrombophilia, osteonecrosis. Glueck CJ Freiberg RA Fontaine RN Tracy T, Wang P,, Clin Orthop Relat Res 2001 386 19 33 11347834 (Pubitemid 32391273)
6. Association of corticosteroids and factor V, prothrombin, and MTHFR gene mutations with avascular osteonecrosis in renal allograft recipients. Celik A Tekis D Saglam F Tunali S, Kabakci N Ozaksoy D, Manisali M Ozcan MA, Meral M Gülay H, Camsari T,, Transplant Proc 2006 38 512 516 10.1016/j. transproceed.2005.12.062 16549163
7. Association of plasminogen activator inhibitor-1 genotype with avascular osteonecrosis in steroid-treated renal allograft recipients. Ferrari P Schroeder V, Anderson S Kocovic L, Vogt B Schiesser D, Marti HP Ganz R, Frey FJ Kohler HP, Transplantation 2002 74 1147 1152 10.1097/00007890-200210270-00016 12438962 (Pubitemid 35216110)
8. The plasminogen activator inhibitor-1 gene, hypofibrinolysis, and osteonecrosis. Glueck CJ Fontaine RN Gruppo R Stroop D, Sieve-Smith L Tracy T, Wang P,, Clin Orthop Relat Res 1999 366 133 146 10627727 (Pubitemid 29439347)
9. Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity. Dawson S Hamsten A Wiman B Henney A, Humphries S,, Arterioscler Thromb 1991 11 183 190 10.1161/01.ATV.11.1.183 1670989
10. Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction. Eriksson P Kallin B van't Hooft FM Bavenholm P, Hamsten A,, Proc Natl Acad Sci USA 1995 92 1851 1855 10.1073/pnas.92.6.1851 7892190
11. Relationship between postrenal transplant osteonecrosis of the femoral head and gene polymorphisms related to the coagulation and fibrinolytic systems in Japanese subjects. Asano T Takahashi KA, Fujioka M Inoue S, Ueshima K Hirata T, Okamoto M Satomi Y, Nishino H Tanaka T, Hirota Y Kubo T, Transplantation 2004 77 220 225 10.1097/01.TP.0000101433.99651.96 14742985
12. Risk period for developing osteonecrosis of the femoral head in patients on steroid treatment. Koo KH Kim R Kim YS Ahn IO, Cho SH Song HR, Park YS Kim H, Wang GJ,, Clin Rheumatol 2002 21 299 303 10.1007/s100670200078 12189457
13. Influence of alcohol intake, cigarette smoking, and occupational status on idiopathic osteonecrosis of the femoralhead. Matsuo K Hirohata T Sugioka Y Ikeda M, Fukuda A,, Clin Orthop Relat Res 1988 234 115 123 3409564
14. Deficient t-PA release and elevated PA inhibitor levels in patients with spontaneous or recurrent deep venous thrombosis. Juhan-Vague I Valadier J Alessi MC Aillaud MF, Ansaldi J Philip-Joet C, Holvoet P Serradimigni A, Collen D,, Thromb Haemost 1987 57 67 72 3109059 (Pubitemid 17159602)
15. Familial high plasminogen activator inhibitor with hypofibrinolysis, a new pathophysiologic cause of osteonecrosis? Glueck CJ Glueck HI, Mieczkowski L Tracy T, Speirs J Stroop D, Thromb Haemost 1993 69 460 465 8322268 (Pubitemid 23146440)
16. Decreased fibrinolytic potential in patients with idiopathic avascular necrosis and transient osteoporosis of the hip. Van Veldhuizen PJ Neff J Murphey MD Bodensteiner D, Skikne BS,, Am J Hematol 1993 44 243 248 10.1002/ajh.2830440405 8237994 (Pubitemid 23328621)
17. Plasminogen activator inhibitor-1 gene: selection of tagging single nucleotide polymorphisms and association with coronary heart disease. Su S Chen S Zhao J Huang J, Wang X Chen R, Gu D,, Arterioscler Thromb Vasc Biol 2006 26 948 954 10.1161/01.ATV.0000204731.17646.f2 16424345 (Pubitemid 43732177)
18. PAI-1 and atherothrombosis. Vaughan DE, J Thromb Haemost 2005 3 1879 83 10.1111/j.1538-7836.2005.01420.x 16102055 (Pubitemid 41716575)
19. Prognostic value of PAI1 in invasive breast cancer: evidence that tumor-specific factors are more important than genetic variation in regulating PAI1 expression. Sternlicht MD Dunning AM, Moore DH Pharoah PD, Ginzinger DG Chin K, Gray JW Waldman FM, Ponder BA Werb Z, Cancer Epidemiol Biomarkers Prev 2006 15 2107 14 10.1158/1055-9965.EPI-06-0351 17119035 (Pubitemid 44877033)
20. The -844 G/A PAI-1 polymorphism is associated with mRNA expression in rheumatoid arthritis. Torres-Carrillo NM Torres-Carrillo N Vázquez-Del Mercado M Delgado-Rizo V, Oregán-Romero E Parra-Rojas I, Mũoz-Valle JF,, Rheumatol Int 2008 28 355 60 10.1007/s00296-007-0453-z 17899094
21. Allele-specific transcription of the PAI-1 gene in human astrocytes. Hultman K Tjarnlund-Wolf A Odeberg J Eriksson P, Jern C,, Thromb Haemost 2010 104 998 1008 10.1160/TH10-04-0243 20806116
22. Glucocorticoids in osteonecrosis of the femoral head: a new understanding of the mechanisms of action. Kerachian MA Sequin C Harvey EJ,, J Steroid Biochem Mol Biol 2009 114 121 8 10.1016/j.jsbmb.2009.02.007 19429441
23. Current concepts on the pathogenesis and natural history of steroid-induced osteonecrosis. Powell C Chang C Gershwin ME,, Clin Rev Allergy Immunol 2010
24. Association study of hypoxia inducible factor 1alpha (HIF1alpha) with osteonecrosis of femoral head in a Korean population. Hong JM Kim TH Chae SC Koo KH, Lee YJ Park EK, Choi JY Ryoo HM, Kim SY,, Osteoarthritis Cartilage 2007 15 688 694 10.1016/j.joca.2006.12.007 17292638 (Pubitemid 46778217)
25. Significant association of SREBP-2 genetic polymorphisms with avascular necrosis in the Korean population. Kim TH Baek JI Hong JM Choi SJ, Lee HJ Cho HJ, Park EK Kim UK, Kim SY,, BMC Med Genet 2008 27 9 94
26. Endothelial nitric oxide synthase gene polymorphisms in patients with nontraumatic femoral head osteonecrosis. Koo KH Lee JS, Lee YJ Kim KJ, Yoo JJ Kim HJ, J Orthop Res 2006 24 1722 1728 10.1002/jor.20164 16779830 (Pubitemid 44203303)
27. Promoter polymorphisms of the vascular endothelial growth factor gene is associated with an osteonecrosis of the femoral head in the Korean population. Kim TH Hong JM, Lee JY Oh B, Park EK Lee CK, Bae SC Kim SY, Osteoarthritis Cartilage 2008 16 287 291 10.1016/j.joca.2007.06.017 17698375 (Pubitemid 351309178)
28. Association of polymorphisms in the Interleukin 23 receptor gene with osteonecrosis of femoral head in Korean population. KIM TH Hong JM, Oh B Cho YS, Lee JY Kim HL, Lee JE Ha MH, Park EK Kim SY, Exp Mol Med 2008 40 418 426 10.3858/emm.2008.40.4.418 18779654
29. Polymorphisms in the Annexin gene family and the risk of osteonecrosis of the femoral head in the Korean population. Kim TH Hong JM Shin ES Kim HJ, Cho YS Lee JY, Lee SH Park EK, Kim SY,, Bone 2009 45 125 131 10.1016/j.bone.2009.03. 670 19345290
30. Factor V Leiden and the prothrombin 20210A gene mutation and osteonecrosis of the knee. Bjorkman A Burtscher IM, Svensson PJ Hillarp A, Besjakov J Benoni G, Arch Orthop Trauma Surg 2005 125 51 55 10.1007/s00402-004- 0760-8 15723247
31. Genetic background of osteonecrosis: associated with thrombophilic mutations? Zalavras CG Vartholomatos G, Dokou E Malizos KN, Clin Orthop Relat Res 2004 422 251 255 15187864 (Pubitemid 38685501)
32. Idiopathic osteonecrosis, hypofibrinolysis, high plasminogen activator inhibitor, high lipoprotein(a), and therapy with Stanozolol. Glueck CJ Freiberg R, Glueck HI Tracy T, Stroop D Wang Y, Am J Hematol 1995 48 213 220 10.1002/ajh.2830480402 7717367